Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Belanoff Joseph K
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
Avg. Two Year Performance
No purchase track record
(40%)
Avg. Sale Return
(19%)
Compound
1 Mo
3 Mo
6 Mo
1 Yr
2 Yr
Average Purchase Return
--
--
--
--
--
Purchase Success Rate
--
--
--
--
--
Average Sale Return
12%
16%
8%
(54%)
(40%)
Sale Success Rate
16 of 24
16 of 24
15 of 24
17 of 24
19 of 24
Corcept Therapeutics Inc.
Drugs
» Biotechnology
Chief Executive Officer, Director:
Holdings:
3.02M
shares
Sentiment
Avg. Two Year Performance
No purchase track record
No sale track record
Last Three Months:
0
Net Amount
Buy:
0
--
Sell:
0
--